Skip to main content
BC Innovations
Feature Story

Precision traffic control

With series A, Perthera wants to become traffic control for precision medicine

Following its July $8.7 million series A funding round, Perthera Inc. is building up its precision medicine information delivery business as it moves toward expanding access to physicians and patients worldwide. The company is pursuing an IT approach to diagnostic management and delivery that gives doctors access to expert guidance on which tests to order and how to interpret results.

Emanuel Petricoin, Perthera's co-founder and CSO, told BioCentury he and fellow co-founder Dendy Young formed the company in 2011 when they sensed the opportunity in precision medicine was starting to take off. The "inflection point

Read Article

Today's Biotech & Pharma News

  • THE DISTILLERY brings you this week's most essential scientific findings in therapeutics, distilled by Innovations editors from a weekly review of more than 400 papers in 41 of the highest-impact journals in the fields of biotechnology, the life sciences and chemistry. The Distillery goes beyond the abstracts to explain the commercial relevance of featured research, including licensing status and companies working in the field, where applicable.

    This week in therapeutics includes important research findings on targets and compounds, grouped first by disease class and then alphabetically by indication.

    This week in techniques includes findings about research tools, disease models and manufacturing processes that have the potential to enable or improve all stages of drug discovery and development.

Subscribe Now
Free Trial